Last updated on February 2020

An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib Docetaxel or Enzalutamide in Metastatic Castration-resistant Prostate Cancer

Brief description of study

The purpose of this study is to assess the safety and efficacy of nivolumab in combination with rucaparib, docetaxel, or enzalutamide in participants with castration-resistant prostate cancer that has spread.

Clinical Study Identifier: NCT03338790

Find a site near you

Start Over

Hospital Britanico De Buenos Aires

Ciudad Autonoma de Buenos Aires, Argentina
  Connect »

Hospital Militar Central

Caba, Argentina
  Connect »